283 related articles for article (PubMed ID: 7520367)
1. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice.
Lafaille JJ; Nagashima K; Katsuki M; Tonegawa S
Cell; 1994 Aug; 78(3):399-408. PubMed ID: 7520367
[TBL] [Abstract][Full Text] [Related]
2. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
Olivares-Villagómez D; Wang Y; Lafaille JJ
J Exp Med; 1998 Nov; 188(10):1883-94. PubMed ID: 9815266
[TBL] [Abstract][Full Text] [Related]
3. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
Matejuk A; Buenafe AC; Dwyer J; Ito A; Silverman M; Zamora A; Subramanian S; Vandenbark AA; Offner H
J Neurosci Res; 2003 Jan; 71(1):89-103. PubMed ID: 12478617
[TBL] [Abstract][Full Text] [Related]
4. 'Lupus-prone' mice are susceptible to organ-specific autoimmune disease, experimental allergic encephalomyelitis.
Zamvil SS; al-Sabbagh A; Nelson PA; Kaul D; Charles MS; Mitchell DJ; Steinman L; Weiner HL; Kuchroo VK
Pathobiology; 1994; 62(3):113-9. PubMed ID: 7524528
[TBL] [Abstract][Full Text] [Related]
5. CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice.
Van de Keere F; Tonegawa S
J Exp Med; 1998 Nov; 188(10):1875-82. PubMed ID: 9815265
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).
Kumar V; Stellrecht K; Sercarz E
J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851
[TBL] [Abstract][Full Text] [Related]
7. Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice.
Hori S; Haury M; Coutinho A; Demengeot J
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8213-8. PubMed ID: 12034883
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
[TBL] [Abstract][Full Text] [Related]
9. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity.
Goverman J; Woods A; Larson L; Weiner LP; Hood L; Zaller DM
Cell; 1993 Feb; 72(4):551-60. PubMed ID: 7679952
[TBL] [Abstract][Full Text] [Related]
11. Immunoregulation of encephalitogenic MBP-NAc1-11-reactive T cells by CD4+ TCR-specific T cells involves IL-4, IL-10 and IFN-gamma.
Adlard K; Tsaknardis L; Beam A; Bebo BF; Vandenbark AA; Offner H
Autoimmunity; 1999; 31(4):237-48. PubMed ID: 10789989
[TBL] [Abstract][Full Text] [Related]
12. Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis.
Furtado GC; Marcondes MC; Latkowski JA; Tsai J; Wensky A; Lafaille JJ
J Immunol; 2008 Oct; 181(7):4648-55. PubMed ID: 18802067
[TBL] [Abstract][Full Text] [Related]
13. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease.
Kumar V; Sercarz EE
J Exp Med; 1993 Sep; 178(3):909-16. PubMed ID: 7688792
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice.
Chen Y; Hancock WW; Marks R; Gonnella P; Weiner HL
J Neuroimmunol; 1998 Mar; 82(2):149-59. PubMed ID: 9585811
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells.
Buenafe AC; Andrew S; Afentoulis M; Offner H; Vandenbark AA
Immunology; 2010 May; 130(1):114-24. PubMed ID: 20059576
[TBL] [Abstract][Full Text] [Related]
17. Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis.
Jiang H; Curran S; Ruiz-Vazquez E; Liang B; Winchester R; Chess L
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8378-83. PubMed ID: 12824465
[TBL] [Abstract][Full Text] [Related]
18. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
[TBL] [Abstract][Full Text] [Related]
19. Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen.
Soos JM; Hobeika AC; Butfiloski EJ; Schiffenbauer J; Johnson HM
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6082-6. PubMed ID: 7541140
[TBL] [Abstract][Full Text] [Related]
20. Rapid depletion of peripheral antigen-specific T cells in TCR-transgenic mice after oral administration of myelin basic protein.
Meyer AL; Benson J; Song F; Javed N; Gienapp IE; Goverman J; Brabb TA; Hood L; Whitacre CC
J Immunol; 2001 May; 166(9):5773-81. PubMed ID: 11313421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
